- Effects of Tirzepatide on the Clinical Trajectory of Patients with Heart Failure, a Preserved Ejection Fraction, and Obesity
- Letter by Lucijanic and Krecak Regarding Article, “Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation”
- Highlights From the Circulation Family of Journals
- Screening for Cardiac Involvement in Carriers of Pathogenic TTR Variants: Proposal for an Approach Based on High-Sensitivity Troponin
- Pulmonary Hypertension: From Therapeutic Nihilism to Multiple Therapeutic Interventions
- Low-Density Lipoprotein Cholesterol Level Distributions Across Different Ages: Implications for Screening Children for Severe and Familial Hypercholesterolemia
- Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?
- Correction to: 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable?
- Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial
- Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM
- Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)
- Randomized Study Comparing a Novel Intranasal Formulation of Bumetanide to Oral and Intravenous Formulations
- Temporal Effects of Plozasiran on Lipids and Lipoproteins in Persistent Chylomicronemia
- A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia
Esprimi il gradimento a questo contenuto
[Totale voti: 0 Media: 0]
